Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement

Journal of Hypertension

Volumn 30, Issue 2, 2012, Pages 253-266

  Head, Geoffrey A ^a   McGrath, Barry P ^b   Mihailidou, Anastasia S ^c   Nelson, Mark R ^d   Schlaich, Markus P ^a   Stowasser, Michael ^e   Mangoni, Arduino A ^f   Cowley, Diane ^e   Brown, Mark A ^g   Ruta, Lee Anne ^h   Wilson, Alison ^h  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Southern Health   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h NATIONAL HEART FOUNDATION OF AUSTRALIA   (Australia)

Author keywords

blood pressure; cardiovascular risk; consensus; guidelines; masked hypertension; white coat hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGE; ARTERIAL STIFFNESS; ARTICLE; AUSTRALIA; BLOOD PRESSURE; BLOOD PRESSURE CUFF; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; COST BENEFIT ANALYSIS; COST CONTROL; EPISODIC HYPERTENSION; HUMAN; HYPERTENSION; MASKED HYPERTENSION; MATERNAL HYPERTENSION; NOCTURNAL HYPERTENSION; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; SEX DIFFERENCE; WHITE COAT HYPERTENSION;

EID: 84855849769     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834de621     Document Type: Article

References (147)

1. National Vascular Disease Prevention Alliance. Guidelines for the assessment of absolute cardiovascular disease risk. Melbourne: Heart Foundation; 2009.
2. National Heart Foundation of Australia, National Blood Pressure and Vascular Disease Advisory Committee. Guide to management of hypertension 2008. Updated August 2009 and December 2010. Web version. 2009. http://www. heartfoundation.org.au/SiteCollectionDocu ments/A-Hypert-Guidelines2008- 2009Update-FINAL.pdf and 2010, http://www.heartfoundation.org.au/ SiteCollectionDocuments/Hyper tensionGuidelines2008to2010Update.pdf.
3. Head G, Mihailidou A, Duggan K, Beilin L, Berry N, Brown M, et al. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ 2010; 340:c1104.
4. Hansen TW, Kikuya M, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals. J Hypertens 2007; 25:1554-1564. (Pubitemid 47056557)
5. McGrath BP. Ambulatory blood pressure monitoring. Med J Aust 2002; 176:588-592. (Pubitemid 34727413)
6. Pickering TG, White WB, Giles TD, Black HR, Izzo JL, Materson BJ, et al. When and how to use self (home) and ambulatory blood pressure monitoring. J Am Soc Hypertens 2010; 4:56-61.
7. Bell KJ, Hayen A, Macaskill P, Craig JC, Neal BC, Fox KM, et al. Monitoring initial response to Angiotensin-converting enzyme inhibitor-based regimens: an individual patient data meta-analysis from randomized, placebo-controlled trials. Hypertension 2010; 56:533-539.
8. Ogedegbe G, Pickering T. Principles and techniques of blood pressure measurement. Cardiol Clin 2010; 28:571-586.
9. Hla KM, Vokaty KA, Feussner JR. Observer error in systolic blood pressure measurement in the elderly. A case for automatic recorders? Arch Intern Med 1986; 146:2373-2376. (Pubitemid 17226091)
10. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens 2009; 27:280-286.
11. Pickering TG. The role of ambulatory monitoring in reducing the errors associated with blood pressure measurement. Herz 1989; 14:214-220. (Pubitemid 19208908)
12. Carney S, Gillies A, Garvey L, Smith A. Direct comparison of repeated same-day self and ambulatory blood pressure monitoring. Nephrology (Carlton) 2005; 10:151-156. (Pubitemid 40776275)
13. Stergiou GS, Bliziotis IA. Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review. Am J Hypertens 2011; 24:123-134.
14. Mesquita-Bastos J, Bertoquini S, Polonia J. Cardiovascular prognostic value of ambulatory blood pressure monitoring in a Portuguese hypertensive population followed up for 8.2 years. Blood Press Monit 2010; 15:240-246.
15. Fagard RH, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. Prognostic significance of ambulatory blood pressure in hypertensive patients with history of cardiovascular disease. Blood Press Monit 2008; 13:325-332.
16. Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 2006; 295:2859-2866. (Pubitemid 43974183)
17. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure and mortality: a population-based study. Hypertension 2005; 45:499-504. (Pubitemid 40411250)
18. Dawes MG, Coats AJ, Juszczak E. Daytime ambulatory systolic blood pressure is more effective at predicting mortality than clinic blood pressure. Blood Press Monit 2006; 11:111-118. (Pubitemid 44084760)
19. Imai Y. Prognostic significance of ambulatory blood pressure. Blood Press Monit 1999; 4:249-256. (Pubitemid 30172910)
20. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282:539-546. (Pubitemid 29380290)
21. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348:2407-2415. (Pubitemid 36682819)
22. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46:156-161. (Pubitemid 40946507)
23. Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens 2010; 28:2036-2045.
24. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983; 249:2792-2798. (Pubitemid 13093711)
25. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793-801. (Pubitemid 24363980)
26. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens 1997; 15:357-364. (Pubitemid 27187138)
27. Bjorklund K, Lind L, Zethelius B, Andren B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003; 107:1297-1302. (Pubitemid 36314414)
28. Bjorklund K, Lind L, Zethelius B, Berglund L, Lithell H. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens 2004; 22:1691-1697. (Pubitemid 39141960)
29. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111:1777-1783. (Pubitemid 40525142)
30. White WB. Ambulatory blood pressure as a predictor of target organ disease and outcome in the hypertensive patient. Blood Press Monit 1999; 4:181-184.
31. Perloff D, Sokolow M, Cowan RM, Juster RP. Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens Suppl 1989; 7:S3-S10. (Pubitemid 19170276)
32. Mancia G, Zanchetti A, AgebitiRosei E, Benemio G, DeCesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997; 95:1464-1470. (Pubitemid 27142804)
33. Verdecchia P, Clement D, Fagard R, Palatini P, Parati G. Blood pressure monitoring. Task force III: target-organ damage, morbidity and mortality. Blood Press Monit 1999; 4:303-317. (Pubitemid 30063992)
34. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 2000; 35:844-851. (Pubitemid 30165336)
35. Elliott HL. 24-h blood pressure control: its relevance to cardiovascular outcomes and the importance of long-acting antihypertensive drugs. J Hum Hypertens 2004; 18:539-543. (Pubitemid 39173529)
36. Staessen JA, Byttebier G, Buntinx F, Celis H, O'Brien ET, Fagard R. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. JAMA 1997; 278:1065-1072. (Pubitemid 27418332)
37. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81:528-536. (Pubitemid 20055961)
38. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005; 45:240-245. (Pubitemid 40179967)
39. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, et al. Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am J Hypertens 1997; 10:1201-1207. (Pubitemid 28005341)
40. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20:2183-2189. (Pubitemid 35388236)
41. Baguet JP, Hammer L, Levy P, Pierre H, Rossini E, Mouret S, et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 2005; 23:521-527. (Pubitemid 40684709)
42. Baguet JP, Levy P, Barone-Rochette G, Tamisier R, Pierre H, Peeters M, et al. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens 2008; 26:885-892. (Pubitemid 351520975)
43. Ikeda T, Matsubara T, Sato Y, Sakamoto N. Circadian blood pressure variation in diabetic patients with autonomic neuropathy. J Hypertens 1993; 11:581-587. (Pubitemid 23154350)
44. Yarows SA, Khoury S, Sowers JR. Cost effectiveness of 24-h ambulatory blood pressure monitoring in evaluation and treatment of essential hypertension. Am J Hypertens 1994; 7:464-468. (Pubitemid 24170539)
45. Pierdomenico SD, Mezzetti A, Lapenna D, Guglielmi M, Mancini M, Salvatore L, et al. 'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of healthcare. Eur Heart J 1995; 16:692-697.
46. Krakoff LR. Cost-effectiveness of ambulatory blood pressure: a reanalysis. Hypertension 2006; 47:29-34. (Pubitemid 43177811)
47. Lorgelly P, Siatis I, Brooks A, Slinn B, Millar-Craig MW, Donnelly R, et al. Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care? Br J Gen Pract 2003; 53:794-796. (Pubitemid 37254125)
48. Swartz SJ, Srivaths PR, Croix B, Feig DI. Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children. Pediatrics 2008; 122:1177-1181.
49. Rodriguez-Roca GC, Alonso-Moreno FJ, Garcia-Jimenez A, Hidalgo-Vega A, Llisterri-Caro JL, Barrios-Alonso V, et al. Cost-effectiveness of ambulatory blood pressure monitoring in the follow-up of hypertension. Blood Press 2006; 15:27-36.
50. Ewald B, Pekarsky B. Cost analysis of ambulatory blood pressure monitoring in initiating antihypertensive drug treatment in Australian general practice. Med J Aust 2002; 176:580-583. (Pubitemid 34727411)
51. Aitken L, Addison C. The cost-effectiveness of ambulatory blood pressure monitoring. Prof Nurse 1996; 12:198-202.
52. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA 1988; 259:225-228. (Pubitemid 18026263)
53. McGrath BP. Is white-coat hypertension innocent? Lancet 1996; 348:630. (Pubitemid 26293804)
54. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 2006; 19:243-250. (Pubitemid 43261503)
55. Ohkubo T, Kikuya M,Metoki H, Asayama K,Obara T,Hashimoto J, et al. Prognosis of 'masked' hypertension and 'white-coat' hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J AmColl Cardiol 2005; 46:508-515. (Pubitemid 41040294)
56. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47:846-853. (Pubitemid 44297554)
57. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848. (Pubitemid 36677141)
58. Parati G, Ulian L, Sampieri L, Palatini P, Villani A, Vanasia A, et al. Attenuation of the 'white-coat effect' by antihypertensive treatment and regression of target organ damage. Hypertension 2000; 35:614-620. (Pubitemid 30108157)
59. Ogedegbe G, Pickering TG, Clemow L, Chaplin W, Spruill TM, Albanese GM, et al. The misdiagnosis of hypertension: the role of patient anxiety. Arch Intern Med 2008; 168:2459-2465.
60. Ugajin T, Hozawa A, Ohkubo T, Asayama K, Kikuya M, Obara T, et al. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch Intern Med 2005; 165:1541-1546. (Pubitemid 41065020)
61. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Polo Friz H, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 2009; 54:226-232.
62. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Grassi G, et al. Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension. J Hypertens 2009; 27:1672-1678.
63. Cuspidi C, Meani S, Sala C, Valerio C, Fusi V, Zanchetti A, et al. How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring? J Hypertens 2007; 25:315-320. (Pubitemid 46071929)
64. Pickering T, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res 2007; 30:.
65. Terawaki H, Metoki H, Nakayama M, Ohkubo T, Kikuya M, Asayama K, et al. Masked hypertension determined by self-measured blood pressure at home and chronic kidney disease in the Japanese general population: the Ohasama study. Hypertens Res 2008; 31:2129-2135.
66. Kawano Y, Horio T, Matayoshi T, Kamide K. Masked hypertension: subtypes and target organ damage. Clin Exp Hypertens 2008; 30:289-296. (Pubitemid 351556174)
67. Drager LF, Pedrosa RP, Diniz PM, Diegues-Silva L, Marcondes B, Couto RB, et al. The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea. Hypertension 2011; 57:549-555.
68. Pickering T, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002; 40:795-796. (Pubitemid 35434896)
69. Yamasue K, Hayashi T, Ohshige K, Tochikubo O, Souma T. Masked hypertension in elderly managerial employees and retirees. Clin Exp Hypertens 2008; 30:203-211. (Pubitemid 351556163)
70. Sharman JE, Hare JL, Thomas S, Davies JE, Leano R, Jenkins C, et al. Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise. Am J Hypertens 2011; 24:898-903.
71. Schultz MG, Hare JL, Marwick TH, Stowasser M, Sharman JE. Masked hypertension is 'unmasked' by low-intensity exercise blood pressure. Blood Press 2011; 20:284-289.
72. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007; 25:2193-2198. (Pubitemid 47537908)
73. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens 2011; 24:52-58.
74. Mallion JM, Genes N, Vaur L, Clerson P, Vaisse B, Bobrie G, et al. Detection of masked hypertension by home blood pressure measurement: is the number of measurements an important issue? Blood Press Monit 2004; 9:301-305.
75. Kawabe H, Saito I. Reproducibility of masked hypertension determined from morning and evening home blood pressure measurements over a 6-month period. Hypertens Res 2007; 30:845-851. (Pubitemid 47578247)
76. Viera AJ, Hinderliter AL, Kshirsagar AV, Fine J, Dominik R. Reproducibility of masked hypertension in adults with untreated borderline office blood pressure: comparison of ambulatory and home monitoring. Am J Hypertens 2010; 23:1190-1197.
77. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117:e510-e526.
78. Rodrigues CS, Bloch KV, da Rocha Nogueira A. Office blood pressure and 24-h ambulatory blood pressure measurements: high proportion of disagreement in resistant hypertension. J Clin Epidemiol 2009; 62:745-751.
79. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens 2001; 14:1263-1269. (Pubitemid 33151484)
80. Campbell P, Ghuman N, Wakefield D, Wolfson L, White WB. Longterm reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly. J Hum Hypertens 2010; 24:749-754.
81. Jaquet F, Goldstein IB, Shapiro D. Effects of age and gender on ambulatory blood pressure and heart rate. J Hum Hypertens 1998; 12:253-257. (Pubitemid 28197284)
82. Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens 2005; 19:801-807. (Pubitemid 41486143)
83. Ejaz AA, Kazory A, Heinig ME. 24-h blood pressure monitoring in the evaluation of supine hypertension and orthostatic hypotension. J Clin Hypertens (Greenwich) 2007; 9:952-955.
84. Mader SL. Aging and postural hypotension. An update. J Am Geriatr Soc 1989; 37:129-137. (Pubitemid 19041110)
85. Lanthier L, Touchette M, Bourget P, St-Georges C, Walker C, Tessier DM. Evaluation of circadian variation of blood pressure by ambulatory blood pressure monitoring in an elderly diabetic population with or without orthostatic hypotension. Geriatr Psychol Neuropsychiatr Vieil 2011; 9:59-66.
86. Istenes I, Keresztes K, Hermanyi Z, Putz Z, Vargha P, Gandhi R, et al. Relationship between autonomic neuropathy and hypertension: are we underestimating the problem? Diabet Med 2008; 25:863-866.
87. Brown MA, Robinson A, Bowyer L, Buddle ML, Martin A, Hargood JL, et al. Ambulatory blood pressure monitoring in pregnancy: what is normal? Am J Obstet Gynecol 1998; 178:836-842. (Pubitemid 28196897)
88. Brown MA, Mangos G, Davis G, Homer C. The natural history of white coat hypertension during pregnancy. BJOG 2005; 112:601-606. (Pubitemid 40675796)
89. Biswas A, Choolani MA, Anandakumar C, Arulkumaran S. Ambulatory blood pressure monitoring in pregnancy induced hypertension. Acta Obstet Gynecol Scand 1997; 76:829-833. (Pubitemid 27429876)
90. Bellomo G, Narducci PL, Rondoni F, Pastorelli G, Stangoni G, Angeli G, et al. Prognostic value of 24-h blood pressure in pregnancy. JAMA 1999; 282:1447-1452. (Pubitemid 29493798)
91. Davis GK, Mackenzie C, Brown MA, Homer CS, Holt J, McHugh L, et al. Predicting transformation from gestational hypertension to preeclampsia in clinical practice: a possible role for 24 h ambulatory blood pressure monitoring. Hypertens Pregnancy 2007; 26:77-87. (Pubitemid 46649345)
92. Bergel E, Carroli G, Althabe F. Ambulatory versus conventional methods for monitoring blood pressure during pregnancy. Cochrane Database Syst Rev 2002:CD001231.
93. Mansoor GA, McCabe EJ, White WB. Long-term reproducibility of ambulatory blood pressure. J Hypertens 1994; 12:703-708. (Pubitemid 24211290)
94. Eguchi K, Hoshide S, Hoshide Y, Ishikawa S, Shimada K, Kario K. Reproducibility of ambulatory blood pressure in treated and untreated hypertensive patients. J Hypertens 2010; 28:918-924.
95. Beltman FW, Heesen WF, Kok RH, Smit AJ, May JF, de Graeff PA, et al. Predictive value of ambulatory blood pressure shortly after withdrawal of antihypertensive drugs in primary care patients. BMJ 1996; 313:404-406. (Pubitemid 26289981)
96. Mallion JM, Maitre A, de Gaudemaris R, Siche JP, Tremel F. Use of ambulatory blood pressure monitoring in the management of antihypertensive therapy. Drugs 1992; 44 (Suppl 1):12-16.
97. Smith DH, Dubiel R, Jones M. Use of 24-h ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan. Am J Cardiovasc Drugs 2005; 5:41-50.
98. White WB. Relating cardiovascular risk to out-of-office blood pressure and the importance of controlling blood pressure 24 h a day.AmJ Med 2008; 121:S2-7. (Pubitemid 351970085)
99. Head G, Chatzivlastou K, Lukoshkova E, Jennings G, Reid CM. A novel measure of the power of the morning blood pressure surge from ambulatory blood pressure recordings. Am J Hypertens 2010; 23: 1074-1081.
100. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
101. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362:1575-1585.
102. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995; 13:1377-1390. (Pubitemid 26015753)
103. Wiinberg N, Hoegholm A, Christensen HR, Bang LE, Mikkelsen KL, Nielsen PE, et al. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 1995; 8:978-986.
104. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund- Bodega°rd K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370:1219-1229. (Pubitemid 47503300)
105. Loredo JS, Nelesen R, Ancoli-Israel S, Dimsdale JE. Sleep quality and blood pressure dipping in normal adults. Sleep 2004; 27:1097-1103. (Pubitemid 39331081)
106. Pickering TG, Kario K. Nocturnal nondipping: what does it augur? Curr Opin Nephrol Hypertens 2001; 10:611-616. (Pubitemid 32783810)
107. Takeda A, Toda T, Fujii T, Matsui N. Bedtime administration of longacting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension. Clin Exp Nephrol 2009; 13:467-472.
108. Guo H, Tabara Y, Igase M, Yamamoto M, Ochi N, Kido T, et al. Abnormal nocturnal blood pressure profile is associated with mild cognitive impairment in the elderly: the J-SHIPP study. Hypertens Res 2010; 33:32-36.
109. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38:852-857. (Pubitemid 34258682)
110. White WB. Blood pressure load and target organ effects in patients with essential hypertension. J Hypertens Suppl 1991; 9:S39-S41.
111. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987; 60:801-806. (Pubitemid 17163439)
112. Weber MA. The 24-h blood pressure pattern: does it have implications for morbidity and mortality? Am J Cardiol 2002; 89:27A-33A.
113. Head GA, Lukoshkova EV. Understanding the morning rise in blood pressure. Clin Exp Pharmacol Physiol 2008; 35:516-521. (Pubitemid 351326791)
114. Li Y, Thijs L, Hansen TW, Kikuya M, Boggia J, Richart T, et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension 2010; 55:1040-1048.
115. Kario K, Ishikawa J, Pickering TG, Hoshide S, Eguchi K, Morinari M, et al. Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res 2006; 29:581-587. (Pubitemid 44430466)
116. Stergiou G, Parati G. Further insights into the 24-h blood pressure profile by home blood pressure monitoring: the issue of morning hypertension. J Hypertens 2009; 27:696-699.
117. Redon J, Bertolin V, Giner V, Lurbe E. Assessment of blood pressure early morning rise. Blood Press Monit 2001; 6:207-210. (Pubitemid 33116418)
118. Kario K, Shimada K, Pickering TG. Abnormal nocturnal blood pressure falls in elderly hypertension: clinical significance and determinants. J Cardiovasc Pharmacol 2003; 41 (Suppl 1):S61-S66. (Pubitemid 36015035)
119. Parati G. Blood pressure variability: its measurement and significance in hypertension. J Hypertens Suppl 2005; 23:S19-25.
120. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000; 36:901-906.
121. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375:895-905.
122. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, et al. Effects of beta blockers and calcium-channel blockers on withinindividual variability in blood pressure and risk of stroke. Lancet Neurol 2010; 9:469-480.
123. Parati G, Omboni S, Rizzoni D, AgabitiRosei E, Mancia G. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens 1998; 16:1685-1691. (Pubitemid 28515496)
124. Li Y, Wang JG, Dolan E, Gao PJ, Guo HF, Nawrot T, et al. Ambulatory arterial stiffness index derived from 24-h ambulatory blood pressure monitoring. Hypertension 2006; 47:359-364. (Pubitemid 43740275)
125. Schillaci G, Parati G. Ambulatory arterial stiffness index: merits and limitations of a simple surrogate measure of arterial compliance. J Hypertens 2008; 26:182-185.
126. Dolan E, Thijs L, Li Y, Atkins N, McCormack P, McClory S, et al. Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 2006; 47:365-370. (Pubitemid 43740276)
127. Garcia-Garcia A, Gomez-Marcos MA, Recio-Rodriguez JI, Gonzalez-Elena LJ, Parra-Sanchez J, Fe Munoz-Moreno M, et al. Relationship between ambulatory arterial stiffness index and subclinical target organ damage in hypertensive patients. Hypertens Res 2010; 34: 180-186.
128. Ben-Dov IZ, Gavish B, Kark JD, Mekler J, Bursztyn M. A modified ambulatory arterial stiffness index is independently associated with all-cause mortality. J Hum Hypertens 2008; 22:761-766.
129. Geddes L, Voelz M, Combs C, Reiner D, Babbs C. Characterization of the oscillometric method for measuring indirect blood pressure. Ann Biomed Eng 1982; 10:271-280. (Pubitemid 13088565)
130. O'Brien E, Petrie J, Littler WA. The British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993; 11:S43-S63.
131. Association for the Advancement of Medical Instrumentation. Electronic or automated sphygmomanometer. ANSI/AAMI S 10-1992. Arlington, Virginia: American National Standard; 1992.
132. British Hypertension Society. Automatic blood pressure measuring devices suitable for use in the clinic and also at home for selfmonitoring. 2004. 2010. http://www.bhsoc.org/bp-monitors/automatic. stm.
133. O'Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, et al. European Society of Hypertension international protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit 2010; 15:23-38.
134. Ng KG, Small CF. Changes in oscillometric pulse amplitude envelope with cuff size: implications for blood pressure measurement criteria and cuff size selection. J Biomed Eng 1993; 15:279-282. (Pubitemid 23188209)
135. O'Brien E, Coats A, Owens P, Petrie J, Padfield PL, Littler WA, et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ 2000; 320:1128-1134. (Pubitemid 30213975)
136. Winnicki M, Canali C, Mormino P, Palatini P. Ambulatory blood pressure monitoring editing criteria: is standardization needed? Hypertension and Ambulatory Recording Venetia Study (HARVEST) Group, Italy. Am J Hypertens 1997; 10:419-427. (Pubitemid 27195977)
137. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23:697-701. (Pubitemid 40523262)
138. Walker SP, Permezel MJ, Brennecke SP, Tuttle LK, Higgins JR. Patient satisfaction with the SpaceLabs 90207 ambulatory blood pressure monitor in pregnancy. Hypertens Pregnancy 2004; 23: 295-301. (Pubitemid 39552302)
139. Musso NR, Vergassola C, Barone C, Lotti G. Ambulatory blood pressure monitoring: how reproducible is it? Am J Hypertens 1997; 10:936-939. (Pubitemid 27380960)
140. Suarez C, del Arco C, Garcia-Polo I. Ambulatory blood pressure monitoring: is the daytime period enough for making clinical decisions? Blood Press Monit 2003; 8:267-270. (Pubitemid 39089950)
141. Stenehjem AE, Os I. Reproducibility of blood pressure variability, white-coat effect and dipping pattern in untreated, uncomplicated and newly diagnosed essential hypertension. Blood Press 2004; 13:214-224. (Pubitemid 39248184)
142. Hernandez-del Rey R, Martin-Baranera M, Sobrino J, Gorostidi M, VinyolesE, Sierra C, et al.Reproducibilityof the circadianbloodpressure pattern in 24-h versus 48-h recordings: the Spanish Ambulatory Blood Pressure Monitoring Registry. J Hypertens 2007; 25:2406-2412. (Pubitemid 350064233)
143. Palatini P, Mormino P, Canali C, Santonastaso M, De Venuto G, Zanata G, et al. Factors affecting ambulatory blood pressure reproducibility. Results of the HARVEST Trial. Hypertension and Ambulatory Recording Venetia Study. Hypertension 1994; 23:211-216. (Pubitemid 24050283)
144. Calvo C, Hermida RC, Ayala DE, Lopez JE, Fernandez JR, Dominguez MJ, et al. The 'ABPM effect' gradually decreases but does not disappear in successive sessions of ambulatory monitoring. J Hypertens 2003; 21:2265-2273. (Pubitemid 38293565)
145. Hermida RC, Calvo C, Ayala DE, Fernandez JR, Ruilope LM, Lopez JE. Evaluation of the extent and duration of the 'ABPM effect' in hypertensive patients. J Am Coll Cardiol 2002; 40:710-717. (Pubitemid 34925618)
146. Hermida RC. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Chronobiol Int 2007; 24:749-775. (Pubitemid 47263103)
147. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Effects of time of antihypertensive treatment on ambulatory blood pressure and clinical characteristics of subjects with resistant hypertension. Am J Hypertens 2010; 23:432-439.